跳至主要内容
临床试验/NCT01310491
NCT01310491已完成不适用

RENEWING HEALTH Large-scale Real-life Study in Finland

South Karelia, Social and Health Care District2 个研究点 分布在 1 个国家目标入组 595 人开始时间: 2011年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
595
试验地点
2
主要终点
Health related quality of life

研究概览

简要总结

The purpose of this trial is to determine if by structured telephone based health coaching programme supported by remote monitoring system among type 2 diabetes, coronary artery disease and heart failure patients the investigators are able to improve their quality of life as measured by the SF-36 questionnaire and reduce a value of HbA1c under 6,5 % among those type 2 diabetes patients who had elevated value of HbA1c when recruited.

详细描述

RENEWING HEALTH is a project covering 9 different European States. It aims at evaluation of innovative telemedicine services using a patient-centred approach and a common rigorous assessment methodology. In 9 European regions in the implementation of health-related information and communication technologies service solutions are already operational at local level for the remote monitoring and the treatment of chronic patients suffering from diabetes,chronic obstructive pulmonary disease or cardiovascular diseases. The services are designed to give patients a central role in the management of their own diseases, fine-tuning the choice and dosage of medications, promoting compliance to treatment, and helping health care professionals to detect early signs of worsening in the monitored pathologies. Every area will designed its own real-life trial with certain common elements.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Capability of filling in questionnaires in Finnish language.
  • Be able to use Remote Patient Monitoring System
  • Be able to use the devices provided
  • Has adequate cognitive capacities to participate
  • In their medical records, one or both of the following diagnoses:
  • a) Type 2 Diabetes, for enrolment
  • diagnosed over 3 months prior to the enrolment and
  • HbA1c > 6,5 % b) Heart Disease, for enrolment
  • Ischemic heart disease or
  • Heart Failure or
  • Atrial fibrillation or
  • Other arrhythmia
  • Be able to walk

排除标准

  • Not willing to participate (e.g., not willing to sign the consent)

结局指标

主要结局

Health related quality of life

时间窗: 12 months

Health related quality of life is assessed by the SF-36 questionnaire.

HbA1c change over time (participants with T2DM only)

时间窗: 12 months

次要结局

  • Weight reduction(12 months)
  • Activity increase(12 months)
  • Alcohol use reduction(12 months)
  • Medication compliance(12 months)
  • Blood pressure reduction(12 months)
  • Smoke cessation(12 months)
  • Cost for the organization(12 months)
  • Satisfaction and usability of the technology and equipments.(12 months)

研究者

发起方
South Karelia, Social and Health Care District
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tuula Karhula

Substitute Director of Elderly Services

South Karelia, Social and Health Care District

研究点 (2)

Loading locations...

相似试验